Donor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched Donors

Clinical trial NCT03615105 · TERMINATED

Trial details

NCT number: NCT03615105
Sponsor: Memorial Sloan Kettering Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Lymphoid Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Myeloid Leukemia (CML)Hodgkin Lymphoma Non-Hodgkin Lymphoma Chronic Lymphocytic Leukemia

Start date: 2018-07-25
Primary completion: 2024-03-06
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.